These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 28441993

  • 1. Randomized, placebo-controlled study of cetirizine and loratadine in children with seasonal allergic rhinitis.
    Nayak AS, Berger WE, LaForce CF, Urdaneta ER, Patel MK, Franklin KB, Wu MM.
    Allergy Asthma Proc; 2017 May 01; 38(3):222-230. PubMed ID: 28441993
    [Abstract] [Full Text] [Related]

  • 2. Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis.
    Meltzer EO, Weiler JM, Widlitz MD.
    J Allergy Clin Immunol; 1996 Feb 01; 97(2):617-26. PubMed ID: 8621847
    [Abstract] [Full Text] [Related]

  • 3. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
    Day JH, Briscoe M, Widlitz MD.
    J Allergy Clin Immunol; 1998 May 01; 101(5):638-45. PubMed ID: 9600501
    [Abstract] [Full Text] [Related]

  • 4. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis.
    Day JH, Briscoe MP, Rafeiro E, Hewlett D, Chapman D, Kramer B.
    Allergy Asthma Proc; 2004 May 01; 25(1):59-68. PubMed ID: 15055564
    [Abstract] [Full Text] [Related]

  • 5. Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system.
    Day JH, Briscoe M, Rafeiro E, Chapman D, Kramer B.
    Ann Allergy Asthma Immunol; 2001 Dec 01; 87(6):474-81. PubMed ID: 11770694
    [Abstract] [Full Text] [Related]

  • 6. A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the Vienna Challenge Chamber (VCC).
    Stübner P, Zieglmayer R, Horak F.
    Curr Med Res Opin; 2004 Jun 01; 20(6):891-902. PubMed ID: 15200748
    [Abstract] [Full Text] [Related]

  • 7. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis.
    Hampel F, Howland W, Van Bavel J, Ratner P.
    J Investig Allergol Clin Immunol; 2004 Jun 01; 14(1):56-63. PubMed ID: 15160443
    [Abstract] [Full Text] [Related]

  • 8. Loratadine versus cetirizine: assessment of somnolence and motivation during the workday.
    Salmun LM, Gates D, Scharf M, Greiding L, Ramon F, Heithoff K.
    Clin Ther; 2000 May 01; 22(5):573-82. PubMed ID: 10868555
    [Abstract] [Full Text] [Related]

  • 9. Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit.
    Day JH, Briscoe MP, Rafeiro E, Ratz JD, Ellis AK, Frankish CW, Chapman D, deGuia EC, Kramer B, Warner C.
    Allergy Asthma Proc; 2005 May 01; 26(4):275-82. PubMed ID: 16270720
    [Abstract] [Full Text] [Related]

  • 10. Effect of cetirizine on symptom severity and quality of life in perennial allergic rhinitis.
    Skoner DP, LaForce CF, Nathan RA, Urdaneta ER, Zielinski MA, Sacavage SD, Franklin KB, Wu MM.
    Allergy Asthma Proc; 2014 May 01; 35(4):338-45. PubMed ID: 24992553
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
    Kuna P, Bachert C, Nowacki Z, van Cauwenberge P, Agache I, Fouquert L, Roger A, Sologuren A, Valiente R, Bilastine International Working Group.
    Clin Exp Allergy; 2009 Sep 01; 39(9):1338-47. PubMed ID: 19438584
    [Abstract] [Full Text] [Related]

  • 12. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis.
    Lockey RF, Widlitz MD, Mitchell DQ, Lumry W, Dockhorn R, Woehler T, Grossman J.
    Ann Allergy Asthma Immunol; 1996 May 01; 76(5):448-54. PubMed ID: 8630719
    [Abstract] [Full Text] [Related]

  • 13. Once-daily cetirizine effective in the treatment of seasonal allergic rhinitis in children aged 6 to 11 years: a randomized, double-blind, placebo-controlled study.
    Pearlman DS, Lumry WR, Winder JA, Noonan MJ.
    Clin Pediatr (Phila); 1997 Apr 01; 36(4):209-15. PubMed ID: 9114992
    [Abstract] [Full Text] [Related]

  • 14. The health-related quality of life effects of once-daily cetirizine HCl in patients with seasonal allergic rhinitis: a randomized double-blind, placebo-controlled trial.
    Noonan MJ, Raphael GD, Nayak A, Greos L, Olufade AO, Leidy NK, Champan D, Kramer B.
    Clin Exp Allergy; 2003 Mar 01; 33(3):351-8. PubMed ID: 12614450
    [Abstract] [Full Text] [Related]

  • 15. Loratadine provides early symptom control in seasonal allergic rhinitis.
    Kaiser HB, Gopalan G, Chung W.
    Allergy Asthma Proc; 2008 Mar 01; 29(6):654-8. PubMed ID: 18831859
    [Abstract] [Full Text] [Related]

  • 16. A randomized controlled trial of cetirizine plus pseudoephedrine versus loratadine plus pseudoephedrine for perennial allergic rhinitis.
    Chiang YC, Shyur SD, Chen TL, Huang LH, Wen TC, Lin MT, Yang HC, Liang PH, Kao YH, Wang TC.
    Asian Pac J Allergy Immunol; 2006 Mar 01; 24(2-3):97-103. PubMed ID: 17136873
    [Abstract] [Full Text] [Related]

  • 17. Comparison of intranasal triamcinolone acetonide with oral loratadine for the treatment of patients with seasonal allergic rhinitis.
    Schoenwetter W, Lim J.
    Clin Ther; 1995 Mar 01; 17(3):479-92. PubMed ID: 7585852
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J, Storms W, Bernstein J, Berger W, Nayak A, Sacks H, Azelastine Cetirizine Trial No. 1 (ACT 1) Study Group.
    Clin Ther; 2005 May 01; 27(5):543-53. PubMed ID: 15978303
    [Abstract] [Full Text] [Related]

  • 19. Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis. The Ebastine Study Group.
    Ratner PH, Lim JC, Georges GC.
    J Allergy Clin Immunol; 2000 Jun 01; 105(6 Pt 1):1101-7. PubMed ID: 10856142
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
    Nayak AS, Philip G, Lu S, Malice MP, Reiss TF, Montelukast Fall Rhinitis Investigator Group.
    Ann Allergy Asthma Immunol; 2002 Jun 01; 88(6):592-600. PubMed ID: 12086367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.